View Archive

Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC, and Pharmacy Times Continuing Education™.

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Developments in the Management of Metastatic HER2-Positive Breast Cancer and Delivery of Patient-Centered Oncology Care

Developments in the Management of Metastatic HER2-Positive Breast Cancer and Delivery of Patient-Centered Oncology Care

January 25, 2022

8:00 PM ET

Live, Interactive Webcast!


Human epidermal growth factor receptor 2 (HER2) expression is a marker of a more aggressive disease and presents in about 25% of breast cancers. The treatment of HER2-positive breast cancer has evolved with increasing availability of HER2-targeted therapies. The appropriate sequencing of therapies for patients with HER2-positive breast cancer can be complex, and pharmacists are integral to ensuring care coordination and providing medication expertise to the multidisciplinary care team. In this program, expert faculty will review recent clinical trial data and guideline recommendations detailing the use of HER2-targeted therapy for first-line treatment. Patient adherence to therapy remains a priority compounded by cost of treatment and concerns of adverse effects of therapy. To ensure optimal patient outcomes, pharmacists must be prepared to make early interventions and assist the oncology care team with identification and management of potential treatment-related adverse effects of HER2-targeted therapies. Oncology pharmacists are positioned to use information gained through this activity to provide education to patients and members of the health care team, monitor drug toxicities, and recommend dose adjustments as appropriate.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Seagen.

Target Audience

This educational activity is directed toward health-system, oncology, and specialty pharmacists, physicians, and nurses who treat patients with Breast Cancer.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Compare and contrast the mechanisms of action and administration of human epidermal growth factor receptor 2 (HER2)-targeted therapies
  • Interpret recent literature evaluating therapies in HER2-positive metastatic breast cancer and characterize subsequent implications for changes in practice paradigms
  • Identify adverse effect profiles and management strategies in efforts to improve adherence to and patient outcomes associated with HER2-targeted therapy


Danielle Roman, PharmD, BCOP
Danielle Roman, PharmD, BCOP
Manager, Oncology Clinical Pharmacy Services
Allegheny Health Network
Pittsburgh, Pennsylvania


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701

Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By